Does EPCORITAMAB-BYSP Cause Neutrophil count decreased? 35 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 35 reports of Neutrophil count decreased have been filed in association with EPCORITAMAB-BYSP. This represents 3.6% of all adverse event reports for EPCORITAMAB-BYSP.
35
Reports of Neutrophil count decreased with EPCORITAMAB-BYSP
3.6%
of all EPCORITAMAB-BYSP reports
11
Deaths
12
Hospitalizations
How Dangerous Is Neutrophil count decreased From EPCORITAMAB-BYSP?
Of the 35 reports, 11 (31.4%) resulted in death, 12 (34.3%) required hospitalization, and 4 (11.4%) were considered life-threatening.
Is Neutrophil count decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EPCORITAMAB-BYSP. However, 35 reports have been filed with the FAERS database.
What Other Side Effects Does EPCORITAMAB-BYSP Cause?
Cytokine release syndrome (369)
Diffuse large b-cell lymphoma (206)
Diffuse large b-cell lymphoma refractory (198)
Pyrexia (79)
Immune effector cell-associated neurotoxicity syndrome (77)
Covid-19 (39)
Hypogammaglobulinaemia (32)
Platelet count decreased (32)
Cytomegalovirus infection (31)
Pneumonia (29)
What Other Drugs Cause Neutrophil count decreased?
CLOZAPINE (2,523)
LENALIDOMIDE (2,471)
PALBOCICLIB (2,224)
CYCLOPHOSPHAMIDE (1,985)
CARBOPLATIN (1,734)
PACLITAXEL (1,562)
RITUXIMAB (1,509)
DEXAMETHASONE (1,320)
BEVACIZUMAB (1,225)
POMALIDOMIDE (1,062)
Which EPCORITAMAB-BYSP Alternatives Have Lower Neutrophil count decreased Risk?
EPCORITAMAB-BYSP vs EPERISONE
EPCORITAMAB-BYSP vs EPHEDRINE
EPCORITAMAB-BYSP vs EPINASTINE
EPCORITAMAB-BYSP vs EPINEPHRINE
EPCORITAMAB-BYSP vs EPINEPHRINE\LIDOCAINE